Fredun Pharmaceuticals Limited reported earnings results for the fourth quarter ended March 31, 2022. For the fourth quarter, the company reported sales was INR 694.47 million compared to INR 411.23 million a year ago. Revenue was INR 718.45 million compared to INR 423.8 million a year ago. Net income was INR 22.96 million compared to INR 7.27 million a year ago. Basic earnings per share from continuing operations was INR 5.18 compared to INR 1.82 a year ago.